(MENAFN- EIN Presswire)
Organ-on-Chip market Size, Share, Competitive Landscape, forecast
PORTLAND, OR, UNITED STATES, October 9, 2024 /EINPresswire / -- Get a Sample Copy of this Report:
The organ-on-chip market is rapidly growing and transforming research in drug discovery and personalized medicine. Here's a snapshot of this emerging industry:
Key Highlights:
.Market Growth: Valued at $103.44 million in 2020, projected to reach $1.6 billion by 2030, growing at a CAGR of 31.1% (2021-2030).
.Technology: Organ-on-chip combines tissue engineering and microfluidics, simulating human organ functions in a lab environment.
.Application Areas: Predominantly used in drug screening, disease modeling, and research into lung, kidney, heart, and liver functions.
Market Drivers:
.Rise in Drug Screening: Organ-on-chip devices help researchers test new drugs, potentially reducing the need for animal testing.
.Demand for Personalized Medicine: Facilitates real-time analysis of cellular and genetic functions, aiding personalized healthcare solutions.
.Shortage of Donor Organs: Laboratory-engineered chips simulate organ functions, addressing the shortage of transplantable organs.
Challenges:
.High Development Costs: Initial costs and the nascent stage of technology development are major restraints.
Segmentation:
.By Organ Type: Includes heart-on-chip, liver-on-chip, lung-on-chip, kidney-on-chip, and intestine-on-chip devices.
.Regional Insights: North America leads the market, but Asia-Pacific is expected to witness significant growth due to rising healthcare investments in India and China.
Key Players:
Companies like Emulate, Inc., Organovo Holdings, and AxoSim Technologies are at the forefront of this technology, driving research and commercial development.
Future Outlook:
.Increased adoption of organ-on-chip technologies in emerging economies.
.A shift towards replacing animal testing with organ-on-chip models for ethical and efficiency reasons.
This game-changing technology is expected to play a pivotal role in the future of healthcare, particularly in drug development and organ transplantation research.
Enquire Before Buying:
David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
MENAFN09102024003118003196ID1108761141
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.